No authoritative reference available. No authoritative reference available. Noncurrent receivable - foreign tax payment. No authoritative reference available. Payment due under settlement agreement, 2015. No authoritative reference available. No authoritative reference available. No authoritative reference available. Number of shares authorized for repurchase. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Amount of payment due at closing under settlement agreement. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Probable Insurance Recoveries included in Estimated Liability. No authoritative reference available. Contractual Amounts Of Companys Forward Exchange Contracts. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The components of net income and other nonowner changes in equity net of related taxes. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Equity in earnings of consolidated subsidiaries, net of tax. No authoritative reference available. Payment due under settlement agreement, 2014. No authoritative reference available. No authoritative reference available. No authoritative reference available. Indemnity And Defense Payments For Asbestos Claims Related To Discontinued Operations. No authoritative reference available. No authoritative reference available. No authoritative reference available. Current recovery of total defense and indemnity payments for Abex claims, in percent. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Cash activity under the Plan B Settlement. No authoritative reference available. No authoritative reference available. No authoritative reference available. Payment due under settlement agreement, 2012. No authoritative reference available. Number of Abex asbestos claims resolved for the period. No authoritative reference available. Initial payment to Federal-Mogul trust required under Plan A Settlement. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Segment Information. No authoritative reference available. Average indemnity payment for resolved Abex Claims. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Condensed consolidating statements of cash flows. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Intercompany accounts payable. No authoritative reference available. Reduction in income tax expense for discrete items. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Access to Abex insurance policies with remaining limits, minimum. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Number of Abex Asbestos Claims Pending At End Of Period. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This item represents disclosure of all significant concentrations of credit risk or market risk arising from the subject financial instrument (as defined), whether from an individual counterparty or groups of counterparties. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Condensed consolidating statements of income. No authoritative reference available. Investment in parent. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Common shares issued for employee incentive, benefit plans and dividend reinvestment program. No authoritative reference available. No authoritative reference available. No authoritative reference available. Subsidiary common stock. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Actual payment received by Company from other party under Plan B Settlement. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Other cash activity associated with asbestos claims related to discontinued operations. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element is used to disclose the entity's entire derivative instruments and hedging activities disclosure and complete disclosure regarding the fair value of financial instruments and the measurements of those instruments, assets, and liabilities as a single block of text. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Intercompany income (expense). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Estimated liability related to Automotive product sale and settlement related to Federal-Mogul bankruptcy. No authoritative reference available. No authoritative reference available. No authoritative reference available. Interest on income tax assessment. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Number of shares expected to be repurchased to offset dilution from share issuances under equity compensation plans. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Shares available for future grants under the Prior Stock Plan and Bonus Plan which were transferred to and are now available for issuance under the 2011 Incentive Plan. No authoritative reference available. No authoritative reference available. No authoritative reference available. Intercompany accounts receivable. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Condensed consolidating balance sheets. No authoritative reference available. No authoritative reference available. No authoritative reference available. Potential additional Plan A Settlement payment over 25 years. No authoritative reference available. Interest received by Cooper related to Federal-Mogul Plan B Settlement payment. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Proceeds from insurance recoveries for asbestos claims related to discontinued operations. No authoritative reference available. No authoritative reference available. No authoritative reference available. Net income per common share basic and diluted. No authoritative reference available. Payment of income tax, including interest, on assessment. No authoritative reference available. Potential payment to Cooper by Federal-Mogul under Plan B Settlement. No authoritative reference available. Amount of loan which is partially paid from debt. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Investment in consolidated subsidiaries. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Basis of Presentation. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Percentage of cash and cash equivalents held at three financial institutions. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Estimated undiscounted liability for pending and future indemnity and defense costs related to Abex asbestos claims for the next 45 years. No authoritative reference available. Defense costs incurred related to Abex asbestos claims for the period. No authoritative reference available. No authoritative reference available. No authoritative reference available. Repayment of borrowings from intercompany loans with consolidated affiliates. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Share based compensation arrangement total awards outstanding number. No authoritative reference available. Proceeds from repayment of intercompany loans by consolidated affiliates. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Effective tax rate after excluding the impact of discrete items. No authoritative reference available. Proceeds from borrowings from intercompany loans with consolidated affiliates. No authoritative reference available. No authoritative reference available. No authoritative reference available. Percentage Of Debt Of Hedged Item. No authoritative reference available. No authoritative reference available. No authoritative reference available. Net cash flow related to the entity's discontinued operations assets and liabilities No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Total Estimated Undiscounted Liability For Asbestos Claims Related To Discontinued Operations No authoritative reference available. No authoritative reference available. No authoritative reference available. Component of net inventories. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Intercompany notes receivable. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Net cash provided by or used from consolidated affiliates, excluding intercompany loans. No authoritative reference available. Remaining amount of payments due under settlement agreement. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Cash used to provide intercompany loans to consolidated affiliates. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Payment due under settlement agreement, 2013. No authoritative reference available. Intercompany notes payable. No authoritative reference available. Subsidiary preferred stock. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The sum of the portions of deferred tax assets as of the balance sheet date for which, based on the weight of available evidence, it is more likely than not will not be realized through future reductions of tax-based income. No authoritative reference available. Receivable for Non-Abex asbestos related insurance settlements. No authoritative reference available. No authoritative reference available. No authoritative reference available. Net deferred taxes recognized in the balance sheet. No authoritative reference available. Total amount of payments due under settlement agreement. No authoritative reference available. Defined benefit plan net periodic benefit cost. No authoritative reference available. No authoritative reference available. No authoritative reference available. Number of Abex asbestos claims filed for the period. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Total estimated insurance recoveries for asbestos claims related to discontinued operations. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The net cash provided by (used in) the operating activities of the entity's discontinued operations assets and liabilities. No authoritative reference available.